Article info
PDFRecent advances in clinical practice
Endoscopy and central reading in inflammatory bowel disease clinical trials: achievements, challenges and future developments
- Correspondence to Dr Klaus Gottlieb, Immunology, Eli Lilly and Company, Indianapolis, Indiana 46225, USA; klaus.gottlieb{at}lilly.com
Citation
Endoscopy and central reading in inflammatory bowel disease clinical trials: achievements, challenges and future developments
Publication history
- Received January 15, 2020
- Revised June 4, 2020
- Accepted June 13, 2020
- First published July 22, 2020.
Online issue publication
January 07, 2021
Article Versions
- Previous version (22 July 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.